REGENERON PHARMACEUTICALS, INC. Comprehensive Income 2010-2026 | REGN
What is comprehensive income?
Comprehensive income includes net income plus other comprehensive items like foreign currency adjustments and unrealized investment gains or losses.
What is REGENERON PHARMACEUTICALS, INC.'s current comprehensive income?
REGENERON PHARMACEUTICALS, INC. (REGN) annual comprehensive income for 2025 was $4.59B, a 2.33% increase from 2024. REGENERON PHARMACEUTICALS, INC. comprehensive income for the quarter ending March 31, 2026 was $661.6M.
What was REGENERON PHARMACEUTICALS, INC.'s comprehensive income in 2024?
REGENERON PHARMACEUTICALS, INC. annual comprehensive income for 2024 was $4.49B, a 9.10% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s comprehensive income in 2023?
REGENERON PHARMACEUTICALS, INC. annual comprehensive income for 2023 was $4.11B, a 0.35% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year comprehensive income CAGR?
REGENERON PHARMACEUTICALS, INC. comprehensive income grew at a compound annual growth rate (CAGR) of 5.44% from FY2020 to FY2025, going from $3.52B to $4.59B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.59B | +2.3% | 10-K |
| FY2024 | $4.49B | +9.1% | 10-K |
| FY2023 | $4.11B | -0.3% | 10-K |
| FY2022 | $4.13B | -48.6% | 10-K |
| FY2021 | $8.02B | +127.7% | 10-K |
| FY2020 | $3.52B | +63.8% | 10-K |
| FY2019 | $2.15B | -11.8% | 10-K |
| FY2018 | $2.44B | +101.2% | 10-K |
| FY2017 | $1.21B | +38.7% | 10-K |
| FY2016 | $874.1M | +47.6% | 10-K |
| FY2015 | $592.4M | +51.3% | 10-K |
| FY2014 | $391.6M | -5.4% | 10-K |
| FY2013 | $413.7M | -44.9% | 10-K |
| FY2012 | $751.0M | +439.6% | 10-K |
| FY2011 | $-221.1M | -104.7% | 10-K |
| FY2010 | $-108.0M | - | 10-K |